Cargando…
Real World Data Studies of Antineoplastic Drugs: How Can They Be Improved to Steer Everyday Use in the Clinic?
There is a growing interest in real world evidence when developing antineoplastic drugs owing to the shorter length of time and low costs compared to randomised controlled trials. External validity of studies in the regulatory phase can be enhanced by complementing randomised controlled trials with...
Autores principales: | George, Gincy, Russell, Beth, Rigg, Anne, Coolen, Anthony C C, Van Hemelrijck, Mieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493103/ https://www.ncbi.nlm.nih.gov/pubmed/37701044 http://dx.doi.org/10.2147/POR.S395959 |
Ejemplares similares
-
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
por: Russell, Beth, et al.
Publicado: (2020) -
Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
por: Russell, Beth, et al.
Publicado: (2020) -
Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
por: Russell, Beth, et al.
Publicado: (2020) -
The incidence and prevalence of upper tract urothelial carcinoma: a systematic review
por: Soualhi, Ahmed, et al.
Publicado: (2021) -
Research engagement among black men with prostate cancer
por: Toms, Charlotte, et al.
Publicado: (2016)